Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat

Journal of Neural Transmission

Volumn 110, Issue 3, 2003, Pages 229-238

  Treseder, S A ^a   Rose, S ^a   Summo, L ^a   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Benserazide; Carbidopa; L amino acid decarboxylase; Monoamine oxidase; NSD 1015; Striatum

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID DECARBOXYLASE; BENSERAZIDE; CARBIDOPA; ENZYME INHIBITOR; LIVER ENZYME; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; LIVER; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDRAZINES; LIVER; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, WISTAR;

EID: 0037349886     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0778-4     Document Type: Article

References (32)

1. 3H] gamma-aminobutyric acid in the basal ganglia of 6-OHDA lesioned rats. Neurosci Lett 121: 223-226
2. Bartholini G, Burkard WP, Pletscher A (1967) Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripherl decarboxylase. Nature 215: 852-853
3. Burkard WP, Gey KF, Pletscher A (1964) Inhibition of decarboxylase of aromatic amino acids by 2,3,4-trihydroxybenzylhydrazine and its seryl derivative. Arch Biochem Biophys 107: 187-196
4. Carlsson A, Kehr W, Lindqvist M, Manusson T, Atack CV (1972) Regulation of monoamine metabolism in the central nervous system. Pharmacol Rev 24(2): 371-382
5. Dluzen D, Reddy A, McDermott J (1992) The aromatic amino-acid decarboxylase inhibitor, NSD-1015, increases release of dopamine - response characteristics. Neuropharmacology 31(12): 1223-1229
6. Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS (1995) Influence of selective inhibition of monoamine oxidase A and B on striatal metabolism of L-DOPA in hemiparkinsonian rats. J Neurochem 65(3): 1213-1220
7. Fowler CJ, Orland L (1980) The nature of the substrate-selective interaction between rat liver mitochondrial monoamine oxidase and oxygen. Biochem Pharmacol 29: 2225-2233
8. Fowler CJB, Benedetti MS (1983) The metabolism of dopamine by both forms of monoamine-oxidase in the rat-brain and its inhibition by cimoxatone. J Neurochem 40: 1534-1541
9. Goshima Y, Kubo T, Misu Y (1986) Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices. Br J Pharmacol 89: 229-234
10. Goshima Y, Nakamura S, Misu Y (1990a) L-DOPA facilitates the release of endogenous norepinephrine and dopamine via presynaptic B1 and B2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. Jpn J Pharmacol 53: 47-56
11. Goshima Y, Nakamura S, Misu Y (1990b) L-Dopa methyl-ester antagonizes competitively L-dopa-induced facilitation of noradrenaline release from rat hypothalamic slices. Jpn J Pharmacol 52: 174-177
12. Goshima Y, Nakamura S, Ohno K, Misu Y (1991) Picomolar concentrations of L-DOPA stereoselectively potentiate activities of presynaptic beta-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices. Neurosci Lett 129: 214-216
13. Goshima Y, Ohno K, Nakamura S, Miyamae T, Misu Y, Akaike A (1993) L-Dopa Induces Ca2+-Dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices. Brain Res 617: 167-170
14. 11C]-raclopride binding in the rat striatum, quantified using PET. Synapse 21: 45-53
15. Hunter LW, Rorie DK, Tyce GM (1993) Inhibition of aromatic 1-amino-acid decarboxylase under physiological conditions - optimization of 3-hydroxybenzylhydrazine concentration to prevent concurrent inhibition of monoamine-oxidase. Biochem Pharmacol 45: 1363-1366
16. Kubo T, Yue J, Goshima Y, Nakamura S, Misu Y (1992) Evidence for L-DOPA systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci Lett 140: 153-156
17. McIntyre IM, McCauley RB, Filipowicz C, Oxenkrug GF (1985) Carbidopa effect on rat brain monoamine oxidase and pineal melatonin. Biol Psych 20: 809-811
18. Misu Y (1995) Neurotransmitter-like actions of L-DOPA. Adv Pharmacol 32: 427-459
19. Misu Y, Goshima Y, Kubo T (1986) Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices. Neurosci Lett 72: 194-198
20. 2+-dependent and tetrodotoxin-sensitive release of glutamate from striata of conscious rat. J Neurochem 65(SS): S154
21. +-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis. J Neurochem 58: 270-275
22. Nakamura S, Yue YL, Goshima Y, Miyamae T, Ueda H, Misu Y (1994) Non-effective doses of exogenously applied L-DOPA itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities in conscious rats. Neurosci Lett 170: 22-26
23. Nakazoto T, Akiyama A (1989) Effect of exogenous L-DOPA on behavior in the rat: an in vivo voltammetric study. Brain Res 490: 332-338
24. Neff NH, Yang HY (1974) Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci 14: 2061-2074
25. 2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis. Br J Pharmacol 123: 805-814
26. Pletscher AG, Gey KF (1962) The effects of a new decarboxylase inhibitor on endogenous and exogenous monoamines. Biochem Pharmacol 12: 223-228
27. Treseder SA, Smith L, Jackson M, Jenner P, Marsden CD (1998) The actions of L-DOPA and dopamine agonists following dopamine depletion in MPTP-treated common marmosets. Br J Pharmacol 123(SS): 251
28. Treseder SA, Jackson M, Rose S, Jenner P, Marsden CD (1999b) The effects of central dopa decarboxylase inhibition on the motor actions of A86929 and quinpirole administered in combination to MPTP-lesioned marmosets. Br J Pharmacol 126(SS): 63
29. Treseder SA, Rose S, Jenner P (1999) The central DOPA decarboxylase inhibitor, NSD-1015, does not prevent L-DOPA-induced circling behaviour in 60HDA-lesioned rats. Br J Pharmacol 127(SS): 24
30. Westlund KN, Denney RM, Kochersberger LM (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230: 181-183
31. Westlund KN, Krakower TJ, Kwan SW, Abell CW (1993) Intracellular distribution of monoamine oxidase A in selected regions of rat and monkey brain and spinal cord. Brain Res 612: 221-230
32. Yue JL, Kakamura S, Ueda H, Misu Y (1994) Endogenously released L-DOPA itself tonically functions to potentiate postsynaptic D2 receptor mediated locomotor activities of conscious rats. Neurosci Lett 170: 107-110